GILD Receives FDA Approval
Gilead Sciences receives FDA approval for Trodelvy to treat triple-negative breast cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Gilead Sciences receives FDA approval for Trodelvy to treat triple-negative breast cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.